NEW YORK ( TheStreet) -- MannKind Corporation (Nasdaq: MNKD) hit a new 52-week low Thursday as it is currently trading at $1.96, below its previous 52-week low of $1.97 with 764,617 shares traded as of 10:15 a.m. ET. Average volume has been 1.6 million shares over the past 30 days. MannKind has a market cap of $359.1 million and is part of the health care sector and drugs industry. Shares are down 17.6% year to date as of the close of trading on Wednesday. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States, Europe, and Asia.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter